A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
Radiation Therapy Oncology Group
Novartis
University of South Florida
Isarna Therapeutics GmbH
Celtic Pharma Development Services
INSYS Therapeutics Inc
Celtic Pharma Development Services